Interesting AVEM Put And Call Options For March 20th

The piece outlines option trade ideas on Avantis Emerging Markets Equity ETF (AVEM), which trades at $81.71. A sell-to-open $81 put (bid $0.05) would set an effective purchase cost of $80.95 and is ~1% out-of-the-money with a 55% probability of expiring worthless, yielding 0.06% (0.35% annualized) if it does. A covered call at the $85 strike (bid $0.05) offers a 4.09% total return to the March 20 expiration and a 61% chance of expiring worthless; implied volatilities are 21% on the put and 29% on the call versus 18% trailing 12-month volatility.

Analysis

Market structure: The options write-ups show micro premia (0.05 USD) with March 20 expiries on AVEM implying trivial carry (0.06% absolute, 0.35% annualized) and an IV skew (puts 21% vs calls 29%) while realized 12‑month vol is 18%. That structure favors owners/long-equity sponsors because option sellers are being paid almost nothing to take equity/assignment risk; market makers and short-dated volatility sellers win only if positions are tiny and directional risk is low. Supply/demand: low option premia signal low demand for hedging now and limited near-term spot conviction in EM equities — flows are likely neutral to slightly outflow-prone unless macro catalysts arrive.

Risk assessment: Tail risks include a USD shock (+2% DXY in 7–14 days) or EM rate/hard-landing headlines that could send AVEM down >8–12% (assignment risk) and spike IV above 40% — immediate gamma risk is asymmetric for short options. Short-term (days–weeks) volatility is regime-dependent around Fed and China datapoints; 3–12 months risks are currency depreciation and widening EM sovereign spreads. Hidden dependencies: ETF liquidity vs underlying emerging market liquidity and tracking error on market stress; option bid prints may evaporate in stressed markets.

Trade implications: Avoid selling naked short-dated puts/calls sized >1–2% NAV; instead use defined-risk structures. Preferred direct plays: small cash-secured put sales or buy-write for position entry only if willing to own AVEM at $80.95, capped to <2% portfolio; alternatively buy 1–3 month put protection or buy low-cost call spreads if seeking upside. Relative/value: pair long AVEM vs short EEM/VWO if conviction on Avantis’ active tilt, rebalancing monthly and sizing 1–2% net exposure.

Contrarian angle: Consensus treats these option premia as trivial — that understates real assignment and liquidity risk in an EM drawdown. The market is underpricing tail hedges (IV gap between calls and puts + realized vol) so buying cheap OTM puts 45–90 days or put spreads becomes asymmetrically attractive if DXY moves +2% or EM PMI prints miss by >3pts. Historical parallel: small premia before 2018 EM episodes; sellers were crushed when flows reversed, so stick to defined-risk, size limits, and explicit stop/roll rules.

Key Decisions for Investors

• Sell 1–2 cash‑secured AVEM Mar‑20 $81 puts size = 1% portfolio only if prepared to acquire AVEM at $80.95; set hard risk rule: buy‑to‑close or roll if AVEM ≤ $77 (5.7% drop) or IV > 40%.
• If seeking yield + equity exposure, buy 1–2% AVEM and sell Mar‑20 $85 covered calls (collect ~0.05) only as tactical trade; cap duration to expiry and reassess if AVEM > +4% or IV rises >10 vol points.
• Avoid naked short-dated option selling >2% NAV. Instead implement defined-risk put spreads (sell $81 / buy $77) with 30–90 day expiries sized 1–2% to collect premium while limiting tail loss.
• Relative trade: go long AVEM (1–2% portfolio) vs short EEM or VWO (equal USD notional) if you prefer Avantis’ active EM exposure; rebalance monthly and unwind if spread moves >3% against you within 30 days.
• Monitor macro triggers for action: DXY move +2% in 7–14 days, China PMI miss >3pts, or EM sovereign spread widening +50bp — any of these should prompt closing of short-put/covered-call legs and adding 45–90 day protective puts.